Guangzhou Improve Med Instrument (300030) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) has a cash flow conversion efficiency ratio of 0.106x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.22 Million ≈ $10.27 Million USD) by net assets (CN¥664.29 Million ≈ $97.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangzhou Improve Med Instrument net asset quality index to measure how much of total assets are equity-financed.
Guangzhou Improve Med Instrument - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Guangzhou Improve Med Instrument's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300030 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Guangzhou Improve Med Instrument Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Improve Med Instrument ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Leysen Jewellery Inc
SHG:603900
|
0.027x |
|
FutureCrest Acquisition Corp.
NYSE:FCRS
|
-0.001x |
|
Fortress Value Acquisition Corp. V Class A Ordinary Shares
NASDAQ:FVAV
|
-0.002x |
|
Sinopower Semiconductor
TWO:6435
|
0.044x |
|
SuperX AI Technology Limited
NASDAQ:SUPX
|
-0.273x |
|
Shanghai Kaichuang Marine International Co Ltd
SHG:600097
|
0.041x |
|
Shenzhen Increase Technology Co Ltd Class A
SHE:300713
|
0.057x |
|
Bangyan Technology Co. Ltd. A
SHG:688132
|
N/A |
Annual Cash Flow Conversion Efficiency for Guangzhou Improve Med Instrument (2006–2025)
The table below shows the annual cash flow conversion efficiency of Guangzhou Improve Med Instrument from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see 300030 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥655.10 Million ≈ $95.86 Million |
CN¥109.90 Million ≈ $16.08 Million |
0.168x | +31.99% |
| 2024-12-31 | CN¥643.86 Million ≈ $94.22 Million |
CN¥81.84 Million ≈ $11.98 Million |
0.127x | +21.26% |
| 2023-12-31 | CN¥762.33 Million ≈ $111.55 Million |
CN¥79.90 Million ≈ $11.69 Million |
0.105x | +102.49% |
| 2022-12-31 | CN¥820.61 Million ≈ $120.08 Million |
CN¥42.48 Million ≈ $6.22 Million |
0.052x | -68.94% |
| 2021-12-31 | CN¥1.03 Billion ≈ $150.78 Million |
CN¥171.74 Million ≈ $25.13 Million |
0.167x | +18.31% |
| 2020-12-31 | CN¥1.00 Billion ≈ $146.74 Million |
CN¥141.27 Million ≈ $20.67 Million |
0.141x | +140.21% |
| 2019-12-31 | CN¥838.26 Million ≈ $122.66 Million |
CN¥49.16 Million ≈ $7.19 Million |
0.059x | -14.65% |
| 2018-12-31 | CN¥815.47 Million ≈ $119.33 Million |
CN¥56.04 Million ≈ $8.20 Million |
0.069x | -53.43% |
| 2017-12-31 | CN¥963.72 Million ≈ $141.02 Million |
CN¥142.19 Million ≈ $20.81 Million |
0.148x | +507.22% |
| 2016-12-31 | CN¥954.18 Million ≈ $139.63 Million |
CN¥23.19 Million ≈ $3.39 Million |
0.024x | +381.92% |
| 2015-12-31 | CN¥930.46 Million ≈ $136.16 Million |
CN¥-8.02 Million ≈ $-1.17 Million |
-0.009x | +93.77% |
| 2014-12-31 | CN¥782.00 Million ≈ $114.43 Million |
CN¥-108.20 Million ≈ $-15.83 Million |
-0.138x | -340.89% |
| 2013-12-31 | CN¥772.70 Million ≈ $113.07 Million |
CN¥44.38 Million ≈ $6.49 Million |
0.057x | +9.57% |
| 2012-12-31 | CN¥687.93 Million ≈ $100.67 Million |
CN¥36.06 Million ≈ $5.28 Million |
0.052x | -12.56% |
| 2011-12-31 | CN¥648.25 Million ≈ $94.86 Million |
CN¥38.86 Million ≈ $5.69 Million |
0.060x | +23.11% |
| 2010-12-31 | CN¥592.55 Million ≈ $86.71 Million |
CN¥28.86 Million ≈ $4.22 Million |
0.049x | -16.93% |
| 2009-12-31 | CN¥563.53 Million ≈ $82.46 Million |
CN¥33.03 Million ≈ $4.83 Million |
0.059x | -81.36% |
| 2008-12-31 | CN¥78.73 Million ≈ $11.52 Million |
CN¥24.76 Million ≈ $3.62 Million |
0.315x | +591.31% |
| 2007-12-31 | CN¥58.27 Million ≈ $8.53 Million |
CN¥2.65 Million ≈ $387.95K |
0.046x | -86.61% |
| 2006-12-31 | CN¥19.33 Million ≈ $2.83 Million |
CN¥6.57 Million ≈ $961.54K |
0.340x | -- |
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more